Annovis Bio, Inc. 10-Q filing
Filed 2026-05-15 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001104659-26-062626
- Form type
- 10-Q
- CIK
- 0001477845
- Primary document
- https://www.sec.gov/Archives/edgar/data/1477845/000110465926062626/anvs-20260331x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Annovis Bio, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-18.0M | - | - |
| Net Income | $-17.6M | - | - |
| Eps Basic | -0.63 | - | - |
| Eps Diluted | -0.63 | - | - |
| Cash And Equivalents | $14.2M | - | - |
| Total Assets | $16.2M | - | - |
| Total Liabilities | $13.1M | - | - |
| Shareholders Equity | $3.1M | - | - |
| Operating Cash Flow | $-9.0M | - | - |